AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,844,191 | -1.1% | 5,085,871 | +2.1% | 0.20% | +9.4% |
| Q2 2023 | $62,546,099 | +10.6% | 4,979,785 | -2.4% | 0.18% | +7.1% |
| Q1 2023 | $56,574,127 | -10.7% | 5,101,364 | -1.7% | 0.17% | -14.2% |
| Q4 2022 | $63,359,607 | +66.2% | 5,189,157 | +29.2% | 0.20% | +43.8% |
| Q3 2022 | $38,123,000 | -13.1% | 4,016,555 | -1.6% | 0.14% | +5.4% |
| Q2 2022 | $43,850,000 | +11.4% | 4,082,872 | -1.8% | 0.13% | +27.5% |
| Q1 2022 | $39,365,000 | -14.8% | 4,156,748 | +3.9% | 0.10% | -5.6% |
| Q4 2021 | $46,209,000 | +57.9% | 4,000,841 | +30.5% | 0.11% | +44.0% |
| Q3 2021 | $29,267,000 | -2.7% | 3,064,607 | -1.7% | 0.08% | -2.6% |
| Q2 2021 | $30,067,000 | -5.1% | 3,118,920 | -2.7% | 0.08% | -15.4% |
| Q1 2021 | $31,680,000 | – | 3,206,490 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |